Reviews6 January 2015
A Systematic Review and Network Meta-analysis
    Author, Article, and Disclosure Information



    The relative efficacy of available treatments of knee osteoarthritis (OA) must be determined for rational treatment algorithms to be formulated.


    To examine the efficacy of treatments of primary knee OA using a network meta-analysis design, which estimates relative effects of all treatments against each other.

    Data Sources:

    MEDLINE, EMBASE, Web of Science, Google Scholar, Cochrane Central Register of Controlled Trials from inception through 15 August 2014, and unpublished data.

    Study Selection:

    Randomized trials of adults with knee OA comparing 2 or more of the following: acetaminophen, diclofenac, ibuprofen, naproxen, celecoxib, intra-articular (IA) corticosteroids, IA hyaluronic acid, oral placebo, and IA placebo.

    Data Extraction:

    Two reviewers independently abstracted study data and assessed study quality. Standardized mean differences were calculated for pain, function, and stiffness at 3-month follow-up.

    Data Synthesis:

    Network meta-analysis was performed using a Bayesian random-effects model; 137 studies comprising 33 243 participants were identified. For pain, all interventions significantly outperformed oral placebo, with effect sizes from 0.63 (95% credible interval [CrI], 0.39 to 0.88) for the most efficacious treatment (hyaluronic acid) to 0.18 (CrI, 0.04 to 0.33) for the least efficacious treatment (acetaminophen). For function, all interventions except IA corticosteroids were significantly superior to oral placebo. For stiffness, most of the treatments did not significantly differ from one another.


    Lack of long-term data, inadequate reporting of safety data, possible publication bias, and few head-to-head comparisons.


    This method allowed comparison of common treatments of knee OA according to their relative efficacy. Intra-articular treatments were superior to nonsteroidal anti-inflammatory drugs, possibly because of the integrated IA placebo effect. Small but robust differences were observed between active treatments. All treatments except acetaminophen showed clinically significant improvement from baseline pain. This information, along with the safety profiles and relative costs of included treatments, will be helpful for individualized patient care decisions.

    Primary Funding Source:

    Agency for Healthcare Research and Quality.


    • 1. Vos TFlaxman ADNaghavi MLozano RMichaud CEzzati Met alYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2163-96. [PMID: 23245607] doi:10.1016/S0140-6736(12)61729-2 CrossrefMedlineGoogle Scholar
    • 2. Guccione AAFelson DTAnderson JJAnthony JMZhang YWilson PWet alThe effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health1994;84:351-8. [PMID: 8129049] CrossrefMedlineGoogle Scholar
    • 3. Kosorok MROmenn GSDiehr PKoepsell TDPatrick DLRestricted activity days among older adults. Am J Public Health1992;82:1263-7. [PMID: 1503169] CrossrefMedlineGoogle Scholar
    • 4. The incidence and prevalence database for procedures. Sunnyvale ,CA: Timely Data Resources; 1995:592-6. Google Scholar
    • 5. White AGBirnbaum HGJanagap CButeau SSchein JDirect and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med2008;50:998-1005. [PMID: 18784547] doi:10.1097/JOM.0b013e3181715111 CrossrefMedlineGoogle Scholar
    • 6. McGettigan PHenry DUse of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med2013;10:e1001388. [PMID: 23424288] doi:10.1371/journal.pmed.1001388 CrossrefMedlineGoogle Scholar
    • 7. Hochberg MCAltman RDApril KTBenkhalti MGuyatt GMcGowan Jet alAmerican College of RheumatologyAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken)2012;64:465-74. [PMID: 22563589] CrossrefMedlineGoogle Scholar
    • 8. McAlindon TEBannuru RRSullivan MCArden NKBerenbaum FBierma-Zeinstra SMet alOARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage2014;22:363-88. [PMID: 24462672] doi:10.1016/j.joca.2014.01.003 CrossrefMedlineGoogle Scholar
    • 9. Juhl CLund HRoos EMZhang WChristensen RA hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis2012;2012:136245. [PMID: 22792458] doi:10.1155/2012/136245 CrossrefMedlineGoogle Scholar
    • 10. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.10. The Cochrane Collaboration; 2011. Accessed at on 13 November 2014. Google Scholar
    • 11. Cooper HHedges LVThe Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994. Google Scholar
    • 12. Dias SWelton NJSutton AJAdes AEEvidence synthesis for decision making 1: introduction. Med Decis Making2013;33:597-606. [PMID: 23804506] doi:10.1177/0272989X13487604 CrossrefMedlineGoogle Scholar
    • 13. Salanti GIndirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Research Synthesis Methods2012;3:80-97. doi:10.1002/jrsm.1037 CrossrefMedlineGoogle Scholar
    • 14. Dias SSutton AJAdes AEWelton NJEvidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making2013;33:607-17. [PMID: 23104435] doi:10.1177/0272989X12458724 CrossrefMedlineGoogle Scholar
    • 15. Franchini ADias SAdes AJansen JWelton NAccounting for correlation in network meta-analysis with multi-arm trials. Research Synthesis Methods2012;3:142-60. doi:10.1002/sim.6321 CrossrefMedlineGoogle Scholar
    • 16. Higgins JPWhitehead ABorrowing strength from external trials in a meta-analysis. Stat Med1996;15:2733-49. [PMID: 8981683] CrossrefMedlineGoogle Scholar
    • 17. Smith TCSpiegelhalter DJThomas ABayesian approaches to random-effects meta-analysis: a comparative study. Stat Med1995;14:2685-99. [PMID: 8619108] CrossrefMedlineGoogle Scholar
    • 18. Lu GAdes AECombination of direct and indirect evidence in mixed treatment comparisons. Stat Med2004;23:3105-24. [PMID: 15449338] CrossrefMedlineGoogle Scholar
    • 19. Baker SGKramer BSThe transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Med Res Methodol2002;2:13. [PMID: 12429069] CrossrefMedlineGoogle Scholar
    • 20. Cipriani AHiggins JPGeddes JRSalanti GConceptual and technical challenges in network meta-analysis. Ann Intern Med2013;159:130-7. [PMID: 23856683] doi:10.7326/0003-4819-159-2-201307160-00008 LinkGoogle Scholar
    • 21. Dias SWelton NJCaldwell DMAdes AEChecking consistency in mixed treatment comparison meta-analysis. Stat Med2010;29:932-44. [PMID: 20213715] doi:10.1002/sim.3767 CrossrefMedlineGoogle Scholar
    • 22. Thorlund KWalter SDJohnston BCFurukawa TAGuyatt GHPooling health-related quality of life outcomes in meta-analysis—a tutorial and review of methods for enhancing interpretability. Research Synthesis Methods2011;2:188-203. doi:10.1002/jrsm.46 CrossrefMedlineGoogle Scholar
    • 23. Pham Tvan der Heijde DAltman RDAnderson JJBellamy NHochberg Met alOMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage2004;12:389-99. [PMID: 15094138] CrossrefMedlineGoogle Scholar
    • 24. Dias SSutton AJWelton NJAdes AEEvidence synthesis for decision making 3: heterogeneity—subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making2013;33:618-40. [PMID: 23804507] doi:10.1177/0272989X13485157 CrossrefMedlineGoogle Scholar
    • 25. Rutjes AWJüni Pda Costa BRTrelle SNüesch EReichenbach SViscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med2012;157:180-91. [PMID: 22868835] doi:10.7326/0003-4819-157-3-201208070-00473 LinkGoogle Scholar
    • 26. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee: evidence-based guideline. 2nd edition. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2013. Accessed at on 13 November 2014. Google Scholar
    • 27. Bannuru RRNatov NSDasi URSchmid CHMcAlindon TETherapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage2011;19:611-9. [PMID: 21443958] doi:10.1016/j.joca.2010.09.014 CrossrefMedlineGoogle Scholar
    • 28. Zhang RXRen KDubner ROsteoarthritis pain mechanisms: basic studies in animal models. Osteoarthritis Cartilage2013;21:1308-15. [PMID: 23973145] doi:10.1016/j.joca.2013.06.013 CrossrefMedlineGoogle Scholar
    • 29. Gulen HAtaoglu HHaliloglu SIsik KProinflammatory cytokines in temporomandibular joint synovial fluid before and after arthrocentesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2009;107:e1-4. [PMID: 19426899] doi:10.1016/j.tripleo.2009.02.006 CrossrefMedlineGoogle Scholar
    • 30. Kirwan JRRankin EIntra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol1997;11:769-94. [PMID: 9429736] CrossrefMedlineGoogle Scholar
    • 31. Zhang WJones ADoherty MDoes paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis2004;63:901-7. [PMID: 15020311] CrossrefMedlineGoogle Scholar
    • 32. Lee CHunsche EBalshaw RKong SXSchnitzer TJNeed for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. Arthritis Rheum2005;53:510-8. [PMID: 16082648] CrossrefMedlineGoogle Scholar
    • 33. Stam WJansen JTaylor SEfficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparison. Open Rheumatol J2012;6:6-20. [PMID: 22582102] doi:10.2174/1874312901206010006 CrossrefMedlineGoogle Scholar
    • 34. Bannuru RRVaysbrot EESullivan MCMcAlindon TERelative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum2014;43:593-9. [PMID: 24216297] doi:10.1016/j.semarthrit.2013.10.002 CrossrefMedlineGoogle Scholar
    • 35. Bellamy NCampbell JRobinson VGee TBourne RWells GIntraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev2006:CD005328. [PMID: 16625636] MedlineGoogle Scholar
    • 36. Arroll BGoodyear-Smith FCorticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ2004;328:869. [PMID: 15039276] CrossrefMedlineGoogle Scholar
    • 37. Bannuru RRNatov NSObadan IEPrice LLSchmid CHMcAlindon TETherapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum2009;61:1704-11. [PMID: 19950318] doi:10.1002/art.24925 CrossrefMedlineGoogle Scholar
    • 38. Bellamy NCampbell JRobinson VGee TBourne RWells GViscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev2006:CD005321. [PMID: 16625635] MedlineGoogle Scholar
    • 39. Cooper NJSutton AJMorris DAdes AEWelton NJAddressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med2009;28:1861-81. [PMID: 19399825] doi:10.1002/sim.3594 CrossrefMedlineGoogle Scholar